Interface

TILE · NASDAQ

$35.64+$0.20 (+0.56%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $35.44

TILE analyst rating

BuyConsensus of 2 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy2
Hold0
Underperform0
Sell0

12-month price target · 6 analysts

Average $46.15 (+29.5% upside)

Low: $41.41
Now: $35.64
High: $52.50

Upgrades and downgrades

The latest rating actions, newest first

TILE analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Barrington Research	Aug 10, 2026	Maintains	Outperform	$36.00 → $45.00	63%
Benchmark	May 19, 2026	Initiates	Buy	$36.00	52%
Barrington Research	Apr 17, 2026	Maintains	Outperform	$36.00	63%
Barrington Research	Jan 23, 2026	Maintains	Outperform	$32.00 → $36.00	63%
Barrington Research	Oct 31, 2025	Maintains	Outperform	$32.00	63%

The case for and against

Updated Oct 23, 2025

Bull case

Interface Inc has demonstrated a strong performance in Q1 of 2025, reporting a 4.1% year-over-year increase in currency-neutral net sales, which reached $301.7 million, with notable contributions from its Americas segment, which grew by 6.4%. The company's success is further underscored by a 13% increase in global billings in the Education sector and a significant 16% rise in Healthcare billings, collectively representing 29% of its gross billings for 2024. The positive momentum in these key segments, along with the effective implementation of its One Interface strategy, positions Interface favorably for continued revenue growth across its operational regions.

Bear case

Interface Inc. reported a decline in its adjusted gross profit margin to 37.7%, which is an expected decrease of 82 basis points from the previous year's 38.6%, primarily attributed to increasing manufacturing and freight costs in its EAAA segment. While the company managed to achieve a GAAP net income of $13 million, or $0.22 per diluted share, this reflected an 8.3% decrease from $14.2 million, or $0.24 per diluted share, a year prior. Overall financial performance indicates rising costs that could continue to pressure profit margins and net income, fostering a cautious outlook on the company's stock.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.